Deal of The Day! Hurry Up, Grab the Special Discount - Save 25% - Ends In 00:00:00 Coupon code: SAVE25
Welcome to Pass4Success

- Free Preparation Discussions

NABP Exam NAPLEX Topic 2 Question 104 Discussion

Actual exam question for NABP's NAPLEX exam
Question #: 104
Topic #: 2
[All NAPLEX Questions]

Select the class of Anti-diabetic medication that works in the specified organ to prevent hyperglycemi

a. Select all that applies. Liver (D)

Show Suggested Answer Hide Answer
Suggested Answer: C

DPP4 Inhibitors, (D)Glucagon-like peptide-1 receptor agonists, (E)Thiazolidinediones (F)Biguanide Sulfonylureas work in beta cells in the pancreas that are still functioning to enhance insulin secretion. Alpha- Glucosidase Inhibitors stop -glucosidase enzymes in the small intestine and delay digestion and absorption of starch and disaccharides which lowers the levels of glucose after meals. DPP4 blocks the degradation ofGLP-1, GIP, and a variety of other peptides, including brain natriuretic peptide. Glucagon-like peptide-1 receptor agonists work in various organs of the body. Glucagon-like peptide-1 receptor agonists enhance glucose homeostasis through: (i) stimulation of insulin secretion; (ii) inhibition of glucagon secretion; (iii) direct and indirect suppression of endogenous glucose production; (iv) suppression of appetite; (v) enhanced insulin sensitivity secondary to weight loss; (vi) delayed gastric emptying, resulting in decreased postprandial hyperglycaemia. Thiazolidinediones are the only true insulin-sensitising agents, exerting their effects in skeletal and cardiac muscle, liver, and adipose tissue. It ameliorates insulin resistance, decreases visceral fat.

Biguanides work in liver, muscle, adipose tissue via activation of AMP-activated protein kinase (AMPK) reduce hepatic glucose production. SGLT2 inhibitors work in the kidneys to inhibit sodium-glucose transport proteins to reabsorb glucose into the blood from muscle cells; overall this helps to improve insulin release from the beta cells of the pancreas.


https://doi.org/10.1093/eurheartj/ehv239

Contribute your Thoughts:

Carman
6 days ago
I'm not sure about this one, but I think A) Sulfonylureas also work in the liver to prevent hyperglycemia. Can anyone confirm?
upvoted 0 times
...
Lai
7 days ago
I agree with you, Miesha. Glucagon-like peptide-1 receptor agonists target the liver specifically to help control blood sugar levels.
upvoted 0 times
...
Miesha
9 days ago
I think the answer is D) Glucagon-like peptide-1 receptor agonists because they work in the liver to prevent hyperglycemia.
upvoted 0 times
...

Save Cancel